SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
DOX

Amdocs Limited (NASDAQ:DOX)

US · Delayed Price · Currency is USD
Technology · Software - Infrastructure
42.69-0.97 (-2.22%)
 
Market cap
$4.59B
Insider Score
Not scored
Health Score
75 Sound
Analyst consensus
Moderate Buy
Listed since
Jun 19, 1998
Website
amdocs.com
Insider Score
––Not scored
DOX Insider Score

No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.

See stocks that are scored

DOX analyst forecast

DOX analyst consensus

Moderate Buy2 ratings
Buy 1 Hold 1 Sell 0

Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.

DOX 12-month price target

No published price targets in the last 12 months.

DOX ratings mix, last 12 months

Buy Hold Sell

Best analysts covering DOX

  • Barclays0%success rate · -6.6% avg return · 3 calls

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

DOX analyst ratings

FirmPrice targetAction
—OppenheimerPerform——Downgraded2026-11-04
—StifelBuy——Reiterated2026-11-04
—StifelBuy——Reiterated2026-05-14
—BarclaysOverweight——Reiterated2026-02-05
—StifelBuy——Reiterated2026-02-04
—Wolfe ResearchPeer Perform——Downgraded2025-11-13
—StifelBuy——Reiterated2025-11-12
—B of A SecuritiesBuy——Reiterated2025-11-12
—BarclaysOverweight——Reiterated2024-11-14
—OppenheimerOutperform——Reiterated2024-11-13
—CitigroupBuy——Reiterated2024-05-09
—BairdNeutral——Reiterated2024-05-09
—BarclaysOverweight——Reiterated2024-02-08
—CitigroupBuy——Reiterated2024-01-17
—OppenheimerOutperform——Reiterated2023-08-03
—BarclaysOverweight——Upgraded2023-05-16
—OppenheimerOutperform——Reiterated2023-05-11
—BairdNeutral——Reiterated2023-02-02
—OppenheimerOutperform——Reiterated2023-02-01
—CitigroupBuy——Reiterated2022-11-09
—BarclaysEqual Weight——Reiterated2022-08-04
—CitigroupBuy——Reiterated2022-08-04
—CitigroupBuy——Reiterated2022-05-12
—JP MorganNeutral——Downgraded2021-12-14
—OppenheimerOutperform——Reiterated2021-08-05
—JP MorganOverweight——Upgraded2020-11-11
—CitigroupBuy——Reiterated2020-05-11
—BairdNeutral——Reiterated2020-02-05
—CitigroupBuy——Reiterated2020-01-15
—JP MorganNeutral——Reiterated2019-11-13
—JP MorganNeutral——Reiterated2019-08-08
—CitigroupBuy——Reiterated2018-08-02
—JefferiesBuy——Upgraded2018-03-19
—StifelBuy——Reiterated2018-01-31
—Stifel NicolausBuy——Reiterated2018-01-31
—JefferiesHold——Reiterated2016-08-01
—JP MorganNeutral——Reiterated2016-07-27
—CitigroupBuy——Reiterated2016-07-27
—BarclaysEqual Weight——Downgraded2015-11-12
—OppenheimerOutperform——Reiterated2015-09-10
—StifelBuy——Reiterated2015-07-30
—Stifel NicolausBuy——Reiterated2015-07-30
—CitigroupBuy——Reiterated2015-04-21
—OppenheimerOutperform——Reiterated2015-03-19
—CitigroupBuy——Reiterated2015-01-28
—CitigroupBuy——Reiterated2015-01-09
—CitigroupBuy——Reiterated2014-10-20
—Wells FargoMarket Perform——Downgraded2014-06-18
—Stifel NicolausBuy——Reiterated2014-05-01
—CitigroupBuy——Reiterated2014-05-01
—StifelBuy——Reiterated2014-05-01
—OppenheimerOutperform——Upgraded2014-01-30
—Stifel NicolausBuy——Reiterated2013-08-01
—StifelBuy——Reiterated2013-08-01
—OppenheimerPerform——Downgraded2013-03-14
—StifelBuy——Reiterated2013-01-31
—Stifel NicolausBuy——Reiterated2013-01-31
—CitigroupBuy——Reiterated2013-01-25
—JP MorganNeutral——Reiterated2012-11-07
—JefferiesHold——Downgraded2012-09-10

DOX earnings vs. estimates

QuarterEPS est.EPS actualRevenue est.Revenue actual
2026-02-031.751.81$1.15B$1.16B
2026-05-131.771.78$1.17B$1.17B
2026-08-051.841.84$1.18B$1.17B
2026-11-031.981.98$1.19B$1.19B
2027-02-02Upcoming1.93—$1.03B—
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.